000			08137nam a22004813i 4500
001			EBC6424219
003			MiAaPQ
005			20240724114749.0
006			m o d |
007			cr cnu||||||||
008			240724s2020 xx o ||||0 eng d
020			_a9789811479595 _q(electronic bk.)
020			_z9789811479571
035			_a(MiAaPQ)EBC6424219
035			_a(Au-PeEL)EBL6424219
035			_a(OCoLC)1227389575
040			_aMiAaPQ _beng _erda _epn _cMiAaPQ _dMiAaPQ
050		4	_aRC854.I53 .C638 2020
082	0		_a616.37
100	1		_aCobucci, Ricardo Ney.
245	1	0	_aPregnancy and Anti-Infective Agents.
250			_a1st ed.
264		1	_aSingapore : _bBentham Science Publishers, _c2020.
264		4	_c©2020.
300			_a1 online resource (186 pages)
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
490	1		_aFrontiers in Anti-Infective Agents Series
505	0		_aCover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- List of Contributors -- Infections in Pregnancy: Maternal and Fetal Risks -- Janaína Crispim Freitas, Diana Gonçalves Dantas, Jaline Pessoa Cavalcante, Júlia Alencar de Medeiros, Juliana Davim Ferreira Gomes and Ricardo Ney Cobucci* -- BACKGROUND -- VIRAL INFECTIONS -- Rubella -- Cytomegalovirus -- Herpes Simplex Virus -- Varicella Zoster Virus -- Parvovirus B19 -- Influenza -- Zika -- Human Immunodeficiency Virus -- BACTERIAL INFECTIONS -- Syphilis -- Group B Streptococcus -- OTHER INFECTIONS -- Toxoplasmosis -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Pharmacodynamics and Pharmacokinetics of Anti-Infective Agents in Pregnant Women -- Neidmar da Mata1,*, Letícia Jales1, Ada Isa Custódio1, Mayara Maria Sales Monteiro2, Wenddy de Lima Cavalcanti Lacerda2 and Raniere da Mata Moura1 -- BACKGROUND -- PHARMACOLOGICAL CONSIDERATIONS AND PHYSIOLOGICAL CHANGES DURING PREGNANCY -- Pharmacokinetics and Pharmacodynamics -- Drug Absorption -- Drug Distribution -- Drug Metabolism -- Elimination of Drugs -- CHANGES IN THE URINARY TRACT DURING PREGNANCY -- CLASSIFICATION OF USED DRUGS IN PREGNANCY -- Classification According to The Categories of Risk of Drugs in Pregnancy -- ANTIBIOTICS AND OTHER ANTI-INFECTIOUS AGENTS IN PREGNANCY -- Betalactam and Related Antibiotics -- Penicillins -- Cephalosporins -- Macrolides -- Nitrofurans -- Aminoglycosides -- Lincosamides -- Clindamycin -- Quinolones -- Antifungals with Application in Pregnancy -- Metronidazole -- Clotrimazole -- Miconazole -- Antivirals -- Acyclovir -- Penciclovir -- Trichloroacetic Acid (TCA) -- Zidovudine/Lamivudine/Nevirapine -- CONCLUSIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES.
505	8		_aClassification and Safety of Anti-Infective Agents During Pregnancy -- Jaline de Melo Pessoa Cavalcante1, Fernanda Coêlho Paiva1, Janaína Crispim Freitas2, Diana Gonçalves Dantas1, Luana Paiva Souza1 and Ricardo Ney Cobucci1 -- BACKGROUND -- ANTIMICROBIALS -- Penicillins -- Cephalosporins -- Imipenem -- Vancomycin -- Tetracyclines -- Chloramphenicol -- Aminoglycosides -- Macrolide -- Sulphonamides -- Quinolones -- Lincosamides -- Rifampicin -- Others -- Metronidazole -- Nitrofurantoin -- Phosphomycin -- ANTIFUNGALS -- ANTIVIRAL AGENTS -- Herpesviridae -- Antiretrovirals -- Anti-influenza -- ANTIMALARIAL AGENTS -- ANTHELMINTIC AGENTS -- Ivermectin -- Benzimidazole (BZs) -- Praziquantel (FDA Category B) -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Treatment of Urinary Tract Infections in Pregnancy -- Ayane Cristine Alves Sarmento, Antônio Carlos Queiroz de Aquino, Michelly Nóbrega Monteiro and Iaponira da Silva Figueiredo Vidal* -- BACKGROUND -- PATHOGENESIS -- RISK FACTORS -- MICROBIOLOGY -- CLASSIFICATION OF UTIS -- Asymptomatic Bacteriuria -- Acute Cystitis -- Acute Pyelonephritis -- ANTIBIOTIC SAFETY IN PREGNANCY -- ANTIBIOTICS IN BREASTFEEDING -- NON ANTIBIOTIC MEASURES -- RECURRENT UTIS -- PREVENTION OF RECURRENT UTIS -- CONCLUSIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Anti-infective Agents for Sexually Transmitted Infections in Pregnancy -- Ana Paula Costa*, Ayane Cristina Sarmento, Maria da Conceição Cornetta and Ana Katherine Gonçalves -- BACKGROUND -- VIRAL GENITAL INFECTIONS -- Human Papillomavirus (HPV) -- Herpes Simplex Vírus (HSV) -- Human Immunodeficiency Virus (HIV) -- Protease Inhibitor -- Integrase Inhibitor Regimen -- Human T-Lymphotropic Virus (HTLV) -- Hepatitis B Virus (HBV) -- Hepatitis C Virus (HCV) -- ZIKA VIRUS (ZIKV).
505	8		_aBACTERIAL GENITAL INFECTIONS -- Neisseria Gonorrhoeae -- Chlamydia Trachomatis (CT) -- Syphilis -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Anti-Infective Agents for HIV in Pregnancy -- Igor Thiago Queiroz*, Themis Rocha Souza, Juliana Mendonça Freire, Alexandre Estevam Montenegro Diniz and Matheus de Araújo Duda -- BACKGROUND -- ANTIRETROVIRALS FOR HIV INFECTED PREGNANT WOMAN -- NUCLEOS(T)IDE ANALOG REVERSE-TRANSCRIPTASE INHIBITORS (NRTI) -- Class Representatives -- Zidovudine or Azidotimidine (ZDV or AZT) -- Tenofovir Disoproxil Fumarate (TDF) -- Abacavir (ABC) -- Lamivudine (3TC) -- Emtricitabine (FTC) -- NON-NUCLEOSIDE ANALOG REVERSE-TRANSCRIPTASE INHIBITORS (NNRTI) -- Class Representatives -- Efavirenz (EFV) -- Nevirapine (NVP) -- Etravirine (ETV) -- Rilpivirine (RPV) -- Doravirine (DOR) -- PROTEASE INHIBITORS (PI) -- Class Representatives -- Atazanavir (ATV) -- Darunavir (DRV) -- Ritonavir (RTV) -- INTEGRASE INHIBITORS (INI) -- Class Representatives -- Dolutegravir (DTG) -- Raltegravir (RAL) -- ENTRY AND FUSION INHIBITORS -- Class Representatives -- Maraviroc (MRV) -- Enfuvirtide (T20) -- CONSIDERATIONS ABOUT USE OF ANTIRETROVIRALS INTRAPARTUM AND AFTER DELIVERY -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Anti-Infective Agents for Vulvovaginal Infections in Pregnancy -- Iaponira da Silva Figueiredo Vidal, Ana Paula Costa, Ana Katherine Gonçalves and Maria da Conceição de Mesquita Cornetta* -- BACKGROUND -- Genital Changes During Pregnancy -- BACTERIAL VAGINOSIS -- TRICHOMONAS VAGINALIS -- CANDIDIASIS -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Anti-Infective Agents for Toxoplasmosis in Pregnancy -- Igor Thiago Queiroz1,2,* and Carolina A. D. Santos2,3,* -- INTRODUCTION.
505	8		_aSCREENING AND DIAGNOSIS -- MATERNAL (PRENATAL) TREATMENT -- Spiramycin -- Pyrimethamine, Sulfadiazine, and Folinic Acid (PSF) -- OTHER POTENTIAL TREATMENT OPTIONS -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Natural Anti-Infective Remedies In Pregnancy -- Silvana Maria Zucolotto* -- BACKGROUND -- Pregnancy and Natural Remedies -- Natural Anti-infective Remedies in Pregnancy -- Cranberry (Vaccinium macrocarpon, Vaccinium oxycoccos) -- Echinacea -- Barberry (Berbery vulgaris) -- Hydrastis canadenses -- Red Raspberry (Rubus idaeus) -- Garlic (Allium sativum L. ) -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Subject Index.
588			_aDescription based on publisher supplied metadata and other sources.
590			_aElectronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
650		0	_aCommunicable diseases in pregnancy.
650		0	_aAnti-infective agents.
655		4	_aElectronic books.
776	0	8	_iPrint version: _aCobucci, Ricardo Ney _tPregnancy and Anti-Infective Agents _dSingapore : Bentham Science Publishers,c2020 _z9789811479571
797	2		_aProQuest (Firm)
830		0	_aFrontiers in Anti-Infective Agents Series
856	4	0	_uhttps://ebookcentral.proquest.com/lib/orpp/detail.action?docID=6424219 _zClick to View
999			_c23152 _d23152